GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chong Kun Dang Pharmaceutical Corp (XKRX:185750) » Definitions » Cyclically Adjusted Price-to-FCF

Chong Kun Dang Pharmaceutical (XKRX:185750) Cyclically Adjusted Price-to-FCF : 30.48 (As of Jun. 07, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Chong Kun Dang Pharmaceutical Cyclically Adjusted Price-to-FCF?

As of today (2025-06-07), Chong Kun Dang Pharmaceutical's current share price is ₩85500.00. Chong Kun Dang Pharmaceutical's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was ₩2,805.16. Chong Kun Dang Pharmaceutical's Cyclically Adjusted Price-to-FCF for today is 30.48.

The historical rank and industry rank for Chong Kun Dang Pharmaceutical's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

XKRX:185750' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 26.47   Med: 31.34   Max: 47.1
Current: 30.87

During the past years, Chong Kun Dang Pharmaceutical's highest Cyclically Adjusted Price-to-FCF was 47.10. The lowest was 26.47. And the median was 31.34.

XKRX:185750's Cyclically Adjusted Price-to-FCF is ranked better than
50.92% of 326 companies
in the Drug Manufacturers industry
Industry Median: 31.405 vs XKRX:185750: 30.87

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Chong Kun Dang Pharmaceutical's adjusted free cash flow per share data for the three months ended in Mar. 2025 was ₩-1,105.214. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ₩2,805.16 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Chong Kun Dang Pharmaceutical Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Chong Kun Dang Pharmaceutical's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chong Kun Dang Pharmaceutical Cyclically Adjusted Price-to-FCF Chart

Chong Kun Dang Pharmaceutical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 37.58 29.90

Chong Kun Dang Pharmaceutical Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.50 30.65 36.16 29.90 27.73

Competitive Comparison of Chong Kun Dang Pharmaceutical's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Chong Kun Dang Pharmaceutical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chong Kun Dang Pharmaceutical's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chong Kun Dang Pharmaceutical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Chong Kun Dang Pharmaceutical's Cyclically Adjusted Price-to-FCF falls into.


;
;

Chong Kun Dang Pharmaceutical Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Chong Kun Dang Pharmaceutical's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=85500.00/2805.16
=30.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chong Kun Dang Pharmaceutical's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Chong Kun Dang Pharmaceutical's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-1105.214/122.5900*122.5900
=-1,105.214

Current CPI (Mar. 2025) = 122.5900.

Chong Kun Dang Pharmaceutical Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -870.315 100.051 -1,066.379
201509 -311.352 100.111 -381.264
201512 -1,647.716 100.220 -2,015.493
201603 -142.645 100.561 -173.893
201606 -1,665.956 100.791 -2,026.274
201609 664.029 101.461 802.310
201612 2,464.294 101.561 2,974.537
201703 1,602.497 102.851 1,910.053
201706 -63.249 102.611 -75.564
201709 1,853.297 103.491 2,195.329
201712 743.616 102.991 885.126
201803 311.958 104.101 367.364
201806 -1,475.602 104.130 -1,737.189
201809 750.700 105.651 871.064
201812 2,044.472 104.351 2,401.822
201903 943.997 104.491 1,107.509
201906 458.499 104.881 535.916
201909 1,506.214 105.200 1,755.192
201912 871.840 105.121 1,016.719
202003 660.729 105.354 768.823
202006 1,334.420 105.112 1,556.310
202009 1,575.058 106.198 1,818.180
202012 1,342.158 105.765 1,555.661
202103 -591.941 107.357 -675.931
202106 616.625 107.579 702.668
202109 -60.637 108.759 -68.348
202112 -3,313.448 109.676 -3,703.582
202203 -343.109 111.848 -376.062
202206 1,361.497 114.072 1,463.159
202209 -556.187 114.715 -594.367
202212 578.461 115.179 615.680
202303 2,236.993 116.507 2,353.782
202306 1,509.960 117.182 1,579.644
202309 5,275.922 118.964 5,436.749
202312 7,397.594 118.837 7,631.212
202403 2,238.315 120.123 2,284.280
202406 -2,401.375 120.007 -2,453.055
202409 -178.170 120.861 -180.719
202412 94.749 121.135 95.887
202503 -1,105.214 122.590 -1,105.214

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Chong Kun Dang Pharmaceutical  (XKRX:185750) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Chong Kun Dang Pharmaceutical Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Chong Kun Dang Pharmaceutical's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Chong Kun Dang Pharmaceutical Business Description

Traded in Other Exchanges
N/A
Address
368 Chungjungro-3Ga, Seodaemun-gu, Seoul, KOR, 120-756
Chong Kun Dang Pharmaceutical Corp. is a manufacturer of antibiotics. The company manufactures and distributes over 130 ethical, OTC pharmaceuticals and pharmaceutical active ingredients, primarily focusing on the application of its advanced technologies in fermentation and organic synthesis. The product range includes Rifampicin (antituberculosis), DMCT (raw material for Minocycline), Cephalosporins, 7-ACA and other intermediates of Cephalosporins, Cyclosporin A (immunosuppressant) and Lovastatin (antihyperlipidaemic agent).

Chong Kun Dang Pharmaceutical Headlines

No Headlines